Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Using NIRSense Sensor Patch to Measure Microvascular Perfusion Responses and Predict Decompensation in Cardiogenic Shock Patients

NCT07825363 is registered in ClinicalTrials.gov with NIRSense Inc. as lead sponsor.

NCT NCT07825363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07825363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Using NIRSense Sensor Patch to Measure Microvascular Perfusion Responses and Predict Decompensation in Cardiogenic Shock Patients
Lead sponsor
NIRSense Inc.
Phase
Observational
Overall status
Recruiting
Start date
June 17, 2025
Completion date
August 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure, acute myocardial infarction, cardiogenic shock